Key highlights

  • Wesfarmers Ltd (ASX:WES) shares were priced at $77.38 as at 22 October 2026, down 3.11% on the day and down approximately 15.00% over the past year.
  • Wesfarmers reported FY26 revenue of $47,274 million, up 3.4%, and NPAT of $2,874 million, up 8.3% excluding prior-year significant items, in its 27 August 2026 release.
  • EBIT was $4,493 million, and the full-year ordinary dividend was 222 cents, up 7.8%, fully franked.

As at 22 October 2026, Wesfarmers Ltd (ASX:WES) shares were priced at $77.38, down 3.11% on the day, and the share performance data shows the stock down approximately 15.00% over the past year. Wesfarmers is a diversified Australian group including Bunnings, Kmart, Officeworks, health and chemicals, energy and fertilisers businesses. Wesfarmers reported FY26 revenue of $47,274 million, up 3.4%, and NPAT of $2,874 million, up 8.3% excluding prior-year significant items, in its 27 August 2026 release.

About Wesfarmers Ltd: business overview

Wesfarmers Limited owns Bunnings Group, Kmart Group (Kmart, Target and Anko), Officeworks, Wesfarmers Health including Priceline Pharmacy, and Wesfarmers Chemicals, Energy and Fertilisers (WesCEF), which includes a lithium business.

FY26 financial results

In an ASX release dated 27 August 2026, Wesfarmers reported revenue of $47,274 million, up 3.4%, EBIT of $4,493 million, up 0.6% (up 7.3% excluding prior-year significant items), and NPAT of $2,874 million, down 1.8% statutory and up 8.3% excluding prior-year significant items. Basic EPS was 253.4 cents. Operating cash flow was $4,272 million, down 6.5%. The full-year ordinary dividend was 222 cents, up 7.8%, fully franked. There were no significant items in FY26; FY25 significant items of $279 million related to the Coregas sale, the BPI property structure and Catch.

Divisions

The release said Bunnings, Kmart Group and WesCEF were the largest earnings contributors. Bunnings and Kmart earnings were supported by everyday low prices, while WesCEF earnings were affected by the timing of higher ammonia prices linked to the Middle East conflict, offset by operational performance and an improved lithium contribution. Spodumene concentrate production was 209kt, above guidance and nameplate capacity, and the lithium refinery ramp-up was affected by intermittent odour issues, with mitigation measures begun late in FY26. Officeworks earnings reflected one-off transformation costs, and Wesfarmers Health delivered higher earnings.

Related sector context

Retailers are influenced by household spending, consumer confidence, interest rates, supplier pricing and tariffs, and the timing of key trading periods. Companies commonly publish trading updates between full results, and report sales, gross margin, store networks and online share alongside profit. Yearly share price changes in the segment can reflect shifts in expectations for spending and housing-related demand as well as company-specific results.

Risks to weigh in

Operating cash flow was lower, WesCEF earnings were affected by ammonia price timing, and the lithium refinery’s ramp-up has faced odour issues. Officeworks is in transformation. Cost-of-living pressures on households, commodity prices and housing activity can affect outcomes.

Catalysts on watch

Items to watch include the lithium refinery ramp-up, Officeworks transformation progress, the first-half trading update and the AGM.

Final word

Wesfarmers’ 27 August 2026 release recorded higher underlying profit and dividend, with lower operating cash flow. Later updates will show division trends.